Gene expression profiling in a renal cell carcinoma cell line: Dissecting VHL and hypoxia-dependent pathways

Molecular Cancer Research

Volumn 1, Issue 6, 2003, Pages 453-462

  Jiang, Yide ^a   Zhang, Wen ^a   Kondo, Keichii ^b   Klco, Jeffery M ^b   St Martin, Thia B ^a   Dufault, Michael R ^a   Madden, Stephen L ^a   Kaelin Jr , William G ^b,c   Nacht, Mariana ^a  

^a Genzyme Molecular Oncology   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANGIOGENESIS; ARTICLE; CARCINOMA CELL; CELL LINE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HYPOXIA; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VHL GENE;

ANOXIA; CARCINOMA, RENAL CELL; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

SALVIA;

EID: 0037395395     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285(21): 1182-1186, 1971.
2. Carmeliet, P. and Jain, R. K. Angiogenesis in cancer and other diseases. Nature, 407(6801): 249-257, 2000.
3. Bunn, H. F. and Poyton, R. O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev., 76(3): 839-885, 1996.
4. Guillemin, K. and Krasnow, M. A. The hypoxic response: huffing and HIFing. Cell, 89(1): 9-12, 1997.
5. Semenza, G. L. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu. Rev. Cell Dev. Biol., 15: 551-578, 1999.
6. Semenza, G. L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol., 88(4): 1474-1480, 2000.
7. Semenza, G. L. HIF-1 and human disease: one highly involved factor. Genes Dev., 14(16): 1983-1991, 2000.
8. Wenger, R. H. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol., 203(Pt. 8): 1253-1263, 2000.
9. Huang, L. E., Gu, J., Schau, M., and Bunn, H. F. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA, 95 (14): 7987-7992, 1998.
10. Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J., and Poellinger, L. Activation of hypoxia-inducible factor α1: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA, 94(11): 5667-5672, 1997.
11. Pugh, C. W., O'Rourke, J. F., Nagao, M., Gleadle, J. M., and Ratcliffe, P. J. Activation of hypoxia-inducible factor-1: definition of regulatory domains within the α subunit. J. Biol. Chem., 272(17): 11205-11214, 1997.
12. Kondo, K. and Kaelin, W. G., Jr. The von Hippel-Lindau tumor suppressor gene. Exp. Cell Res., 264(1): 117-125, 2001.
13. Clifford, S. C. and Maher, E. R. Von Hippel-Lindau disease: clinical and molecular perspectives. Adv. Cancer Res., 82: 85-105, 2001.
14. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E., Pavletich, N., Chau, V., and Kaelin, W. G. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol., 2(7): 423-427, 2000.
15. Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., and Conaway, J. W. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA, 97(19): 10430-10435, 2000.
16. Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G. W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., and Maxwell, P. H. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem., 275(33): 25733-25741, 2000.
17. Tanimoto, K., Makino, Y., Pereira, T., and Poellinger, L. Mechanism of regulation of the hypoxia-inducible factor-1 α by the von Hippel-Lindau tumor suppressor protein. EMBO J., 19(16): 4298-4309, 2000.
18. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., and Kaelin, W. G., Jr. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science, 292(5516): 464-468, 2001.
19. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292(5516): 468-472, 2001.
20. Yu, F., White, S. B., Zhao, Q., and Lee, F. S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA, 98(17): 9630-9635, 2001.
21. Wiesener, M. S., Munchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jurgensen, J. S., Gruber, G., Maxwell, P. H., Loning, S. A., Frei, U., Maher, E. R., Grone, H. J., and Eckardt, K. U. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res., 61(13): 5215-5222, 2001.
22. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., Jr., and Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA, 93 (20): 10595-10599, 1996.
23. Gnarra, J. R., Zhou, S., Merill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., and Linehan, W. M. Posttranscriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA, 93(20): 10589-10594, 1996.
24. Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., and Marme, D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res., 56(10): 2299-2301, 1996.
25. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399(6733): 271-275, 1999.
26. Livingston, D. M. and Shivdasani, R. Toward mechanism-based cancer care. JAMA, 285(5): 588-593, 2001.
27. Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., and Livingston, D. M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med., 6(12): 1335-1340, 2000.
28. Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., and Ratcliffe, P. J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA, 94(15): 8104-8109, 1997.
29. Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., and Johnson, R. S. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res., 60(15): 4010-4015, 2000.
30. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. Serial analysis of gene expression. Science, 270(5235): 484-487, 1995.
31. Motzer, R. J., Bander, N. H., and Nanus, D. M. Renal-cell carcinoma. N. Engl. J. Med., 335(12): 865-875, 1996.
32. Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., and Maxwell, P. H. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell, 1(5): 459-468, 2002.
33. Kaplan, R., Zaheer, A., Jaye, M., and Lim, R. Molecular cloning and expression of biologically active human glia maturation factor-β. J. Neurochem., 57(2): 483-490, 1991.
34. Maher, E. R., Kaelin, W. G., Jr. von Hippel-Lindau disease. Medicine (Baltimore), 76(6): 381-391, 1997.
35. Templeton, N. S., Brown, P. D., Levy, A. T., Margulies, I. M., Liotta, L. A., and Stetler-Stevenson, W. G. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res., 50(17): 5431-5437, 1990.
36. Koochekpour, S., Jeffers, M., Wang, P. H., Gong, C., Taylor, G. A., Roessler, L. M., Stearman, R., Vasselli, J. R., Stetler-Stevenson, W. G., Kaelin, W. G., Jr., Linehan, W. M., Klausner, R. D., Gnarra, J. R., and Vande Woude, G. F. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol. Cell. Biol., 19(9): 5902-5912, 1999.
37. Nagase, H. and Woessner, J. F., Jr., Matrix metalloproteinases. J. Biol. Chem., 274(31): 21491-21494, 1999.
38. Stetler-Stevenson, W. G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest., 103(9): 1237-1241, 1999.
39. Vu, T. H. and Werb, Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev., 14(17): 2123-2133, 2000.
40. Cubbage, M. L., Suwanichkul, A., and Powell, D. R. Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. J. Biol. Chem., 265(21): 12642-12649, 1990.
41. Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., and Plate, K. H. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene, 19(48): 5435-5443, 2000.
42. Seagroves, T. and Johnson, R. Two HIFs may be better than one. Cancer Cell, 1(3): 211-213, 2002.
43. Lal, A., Peters, H., St Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H., van der Kogel, A. J., and Riggins, G. J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst., 93(17): 1337-1343, 2001.
44. Denko, N., Schindler, C., Koong, A., Laderoute, K., Green, C., and Giaccia, A. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin. Cancer Res., 6(2): 480-487, 2000.
45. Iozzo, R. V. and San Antonio, J. D. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest., 108(3): 349-355, 2001.
46. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagibrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92(6): 735-745, 1998.
47. Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Dano, K., Appella, E., and Blasi, F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J., 9(2): 467-474, 1990.
48. Graham, C. H., Forsdike, J., Fitzgerald, C. J., and Macdonald-Goodfellow, S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer, 80(4): 617-623, 1999.
49. Graham, C. H., Fitzpatrick, T. E., and McCrae, K. R. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood, 91(9): 3300-3307, 1998.
50. Shattil, S. J., O'Toole, T., Eigenthaler, M., Thon, V., Williams, M., Babior, B. M., and Ginsberg, M. H. β3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin β3 subunit. J. Cell Biol., 131(3): 807-816, 1995.
51. Li, D., Desai-Yajnik, V., Lo, E., Schapira, M., Abagyan, R., and Samuels, H. H. NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol. Cell. Biol., 19(10): 7191-7202, 1999.
52. Bruick, R. K. and McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294(5545): 1337-1340, 2001.
53. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107(1): 43-54, 2001.
54. Semenza, G. L. Hif-1, o(2), and the 3 phds. How animal cells signal hypoxia to the nucleus. Cell, 107(1): 1-3, 2001.
55. Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., and Finn, O. J. Identification of Cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J. Exp. Med., 194(9): 1313-1324, 2001.
56. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science, 276(5316): 1268-1272, 1997.
57. Buckhaults, P., Rago, C., St Croix, B., Romans, K. E., Saha, S., Zhang, L., Vogelstein, B., and Kinzler, K. W. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res., 61(19): 6996-7001, 2001.
58. Munier, F. L., Korvatska, E., Djemai, A., Le Paslier, D., Zografos, L., Pescia, G., and Schorderet, D. F. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet., 15(3): 247-251, 1997.
59. Cheng, Y. and Lotan, R. Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor. J. Biol. Chem., 273(52): 35008-35015, 1998.
60. Csiszar, K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol., 70: 1-32, 2001.
61. Jourdan-Le Saux, C., Le Saux, O., Donlon, T., Boyd, C. D., and Csiszar, K. The human lysyl oxidase-related gene (LOXL2) maps between markers D8S280 and D8S278 on chromosome 8p21.2-p21.3. Genomics, 51(2): 305-307, 1998.
62. Saito, H., Papaconstantinou, J., Sato, H., and Goldstein, S. Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence. J. Biol. Chem., 272(13): 8157-8160, 1997.
63. Cerf-Bensussan, N., Jarry, A., Brousse, N., Lisowska-Grospierre, B., Guy-Grand, D., and Griscelli, C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur. J. Immunol., 17(9): 1279-1285, 1987.
64. Ohkubo, S., Ogi, K., Hosoya, M., Matsumoto. H., Suzuki, N., Kimura, C., Ondo, H., and Fujino, M. Specific expression of human endothelin-2 (ET-2) gene in a renal adenocarcinoma cell line. Molecular cloning of cDNA encoding the precursor of ET-2 and its characterization. FEBS Lett., 274(1-2): 136-140, 1990.
65. Saida, K., Hashimoto, M., Mitsui, Y., Ishida, N., and Uchide, T. The prepro vasoactive intestinal contractor (VIC)/endothelin-2 gene (EDN2): structure, evolution, production, and embryonic expression. Genomics, 64(1): 51-61, 2000.
66. Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., Koch, C., Evans, S., Ibrahim, H., Le, Q. T., Terris, D. J., and Giaccia, A. J. Candidate genes for the hypoxic tumor phenotype. Cancer Res., 60(4): 883-887, 2000.
67. Yamaguchi, A., Hori, O., Stern, D. M., Hartmann, E., Ogawa, S., and Tohyama, M. Stress-associated endoplasmic reticulum protein 1 (SERP1)/ribosome-associated membrane protein 4 (RAMP4) stabilizes membrane proteins during stress and facilitates subsequent glycosylation. J. Cell Biol., 147(6): 1195-1204, 1999.
68. Whitehouse, D. B., Putt, W., Lovegrove, J. U., Morrison, K., Hollyoake, M., Fox, M. F., Hopkinson, D. A., and Edwards, Y. H. Phosphoglucomutase I: complete human and rabbit mRNA sequences and direct mapping of this highly polymorphic marker on human chromosome 1. Proc. Natl. Acad. Sci. USA, 89(1): 411-415, 1992.
69. Bulavin, D. V., Higashimoto, Y., Popoff, I. J., Gaarde, W. A., Basrur, V., Potapova, O., Appella, E., and Fornace, A. J., Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature, 411(6833): 102-107, 2001.
70. Gallagher, A. R., Cedzich, A., Gretz, N., Somlo, S., and Witzgall, R. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc. Natl. Acad. Sci. USA, 97(8): 4017-4022, 2000.
71. Iliopoulos, O., Kibel, A., Gray, S., and Kaelin, W. G., Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med., 1(8): 822-826, 1995.
72. Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., and Ratcliffe, P. J. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene, 19(54): 6297-6305, 2000.
73. Nacht, M., Ferguson, A. T., Zhang, W., Petroziello, J. M., Cook, B. P., Gao, Y. H., Maguire, S., Riley, D., Coppola, G., Landes, G. M., Madden, S. L., and Sukumar, S. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res., 59(21): 5464-5470, 1999.
74. Nacht, M., Dracheva, T., Gao, Y., Fujii, T., Chen, Y., Player, A., Akmaev, V., Cook, B., Dufault, M., Zhang, M., Zhang, W., Guo, M., Curran, J., Han, S., Sidransky, D., Buetow, K., Madden, S. L., and Jen, J. Molecular characteristics of non-small cell lung cancer. Proc. Natl. Acad. Sci. USA, 98(26): 15203-15208, 2001.
75. Porter, D. A., Krop, I. E., Nasser, S., Sgroi, D., Kaelin, C. M., Marks, J. R., Riggins, G., and Polyak, K. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res., 61(15): 5697-5702, 2001.
76. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F. M., Lubensky, I., Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7(1): 85-90, 1994.
77. Morgenstern, J. P. and Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18(12): 3587-3596, 1990.